FDA Drug Application (206162) for LYNPARZA by ASTRAZENECA PHARMS

Back to FDA Applications sponsored by ASTRAZENECA PHARMS

Application Number206162
Product Number001
FormCAPSULE;ORAL
Dosage50MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLYNPARZA
Active IngredientOLAPARIB



Back to FDA Applications sponsored by ASTRAZENECA PHARMS